From The Advisory Board

Expert Perspectives on Breast Cancer Awareness Month

Expert Perspectives on Breast Cancer Awareness Month

Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.

Reflections on Patient Perspectives and Survivorship from the 2013 Breast Cancer Symposium

Reflections on Patient Perspectives and Survivorship from the 2013 Breast Cancer Symposium

ChemotherapyAdvisor.com Editorial Board Member Don S. Dizon discusses survivorship issues from the 2013 Breast Cancer Symposium.

Q&A with Mark Socinski, MD, on the POINTBREAK Trial of Maintenance Therapy for NSCLC

Q&A with Mark Socinski, MD, on the POINTBREAK Trial of Maintenance Therapy for NSCLC

Editorial Advisory Board member Dr. Socinski discusses the key clinical insights brought to light by the POINTBREAK trial, presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

Dr. Jeffrey Farma Offers Overview of Translational Research at ASCO GI

Dr. Jeffrey Farma Offers Overview of Translational Research at ASCO GI

An expert reviews the new maintenance, second- and third-line therapies for colorectal cancer treatment presented at the 2013 Gastrointestinal Cancers Symposium.

Active Surveillance for Low-Risk Prostate Cancer May Improve Quality of Life

Active Surveillance for Low-Risk Prostate Cancer May Improve Quality of Life

In this article, Advisory Board member Neal Shore, MD, FACS, discusses barriers to clinicians recommending active surveillance for men with low-risk prostate cancer.

New Treatments for Metastatic Colorectal Cancer

New Treatments for Metastatic Colorectal Cancer

Several new therapies for metastatic colorectal cancer have been developed and refined, changing the way the disease can be treated.

Sentinel Lymph Nodes for Melanoma: To Biopsy or Not?

Sentinel Lymph Nodes for Melanoma: To Biopsy or Not?

Advisory Board Member Dr. Farma reviews the current recommendations for using sentinel lymph node biopsy in patients with melanoma.

A 57-Year-Old Male with Rising PSA and Prior Negative Transrectal Biopsies

A 57-Year-Old Male with Rising PSA and Prior Negative Transrectal Biopsies

This patient, who had an increasing PSA level, was found to have abnormal PCA3 urine test results.

The Changing Landscape of Urology

The Changing Landscape of Urology

Advisory Board member Neal D. Shore, MD, FACS relates how vital it is that urologists recognize the changing demands of the field.

A Review of New Microhematuria Guidelines from the American Urological Association

A Review of New Microhematuria Guidelines from the American Urological Association

The guidelines include several departures from past recommendations on the diagnosis, workup, and evaluation of microhematuria.

Sign Up for Free e-newsletters

Enter Our April Contest

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs